NCT00823745View on ClinicalTrials.gov

Radiolabel ADME (Absorption, Distribution, Metabolism, and Excretion) Study Of [14C] PF-00868554 In Healthy Adult Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
HCV
Interventions
DRUG

[14C]-PF-00868554

solution, single dose

Trial Locations (1)

98415

Pfizer Investigational Site, Tacoma

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00823745 - Radiolabel ADME (Absorption, Distribution, Metabolism, and Excretion) Study Of [14C] PF-00868554 In Healthy Adult Male Subjects | Biotech Hunter | Biotech Hunter